CASI Pharma (CASI) Reports Q3 Loss of $0.05
Tweet
Share
E-mailGet Alerts CASI Hot Sheet
Join SI Premium – FREE
CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.05), versus ($0.07) reported last year.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Capstone Energy+, Inc. (CEPL) Reports Q2 Loss of $0.03
- 22nd Century Group (XXII) Misses Q2 EPS by 9800c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
